12:00 AM
 | 
Jul 19, 2010
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Amunix, Versartis preclinical data

In a mouse model of diabetes induced obesity, 10 mg/kg VRS-859 every 2 days plus 20 mg/kg AMX-808 twice daily led to significant weight loss compared to VRS-859 alone. Additionally, significant reductions in...

Read the full 153 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >